These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 36275758)

  • 41. Lipocalin-2 deficiency or blockade protects against aortic abdominal aneurysm development in mice.
    Tarín C; Fernandez-Garcia CE; Burillo E; Pastor-Vargas C; Llamas-Granda P; Castejón B; Ramos-Mozo P; Torres-Fonseca MM; Berger T; Mak TW; Egido J; Blanco-Colio LM; Martín-Ventura JL
    Cardiovasc Res; 2016 Aug; 111(3):262-73. PubMed ID: 27229458
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Targeting mitochondrial fission as a potential therapeutic for abdominal aortic aneurysm.
    Cooper HA; Cicalese S; Preston KJ; Kawai T; Okuno K; Choi ET; Kasahara S; Uchida HA; Otaka N; Scalia R; Rizzo V; Eguchi S
    Cardiovasc Res; 2021 Feb; 117(3):971-982. PubMed ID: 32384150
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Deficiency of cathepsin S attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice.
    Qin Y; Cao X; Guo J; Zhang Y; Pan L; Zhang H; Li H; Tang C; Du J; Shi GP
    Cardiovasc Res; 2012 Dec; 96(3):401-10. PubMed ID: 22871592
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Allosteric activation of PP2A inhibits experimental abdominal aortic aneurysm.
    Zhou X; Zhang C; Xie F; Wei W; Li R; Xu Q; Wang Y; Klenotic PA; Narla G; Dong N; Lin Z
    Clin Sci (Lond); 2021 Sep; 135(17):2085-2097. PubMed ID: 34402501
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Protective effect of suppressor of cytokine signalling 1-based therapy in experimental abdominal aortic aneurysm.
    Bernal S; Lopez-Sanz L; Jimenez-Castilla L; Prieto I; Melgar A; La Manna S; Martin-Ventura JL; Blanco-Colio LM; Egido J; Gomez-Guerrero C
    Br J Pharmacol; 2021 Feb; 178(3):564-581. PubMed ID: 33227156
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gut microbiome dysbiosis contributes to abdominal aortic aneurysm by promoting neutrophil extracellular trap formation.
    Tian Z; Zhang Y; Zheng Z; Zhang M; Zhang T; Jin J; Zhang X; Yao G; Kong D; Zhang C; Wang Z; Zhang Q
    Cell Host Microbe; 2022 Oct; 30(10):1450-1463.e8. PubMed ID: 36228585
    [TBL] [Abstract][Full Text] [Related]  

  • 47. LncRNA H19 promotes vascular inflammation and abdominal aortic aneurysm formation by functioning as a competing endogenous RNA.
    Sun Y; Zhong L; He X; Wang S; Lai Y; Wu W; Song H; Chen Y; Yang Y; Liao W; Liao Y; Bin J
    J Mol Cell Cardiol; 2019 Jun; 131():66-81. PubMed ID: 30991034
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The preventive effect of fish oil on abdominal aortic aneurysm development.
    Kugo H; Zaima N; Mouri Y; Tanaka H; Yanagimoto K; Urano T; Unno N; Moriyama T
    Biosci Biotechnol Biochem; 2016 Jun; 80(6):1186-91. PubMed ID: 27022887
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mesenchymal Stem Cells Attenuate NADPH Oxidase-Dependent High Mobility Group Box 1 Production and Inhibit Abdominal Aortic Aneurysms.
    Sharma AK; Salmon MD; Lu G; Su G; Pope NH; Smith JR; Weiss ML; Upchurch GR
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):908-18. PubMed ID: 26988591
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Kallistatin limits abdominal aortic aneurysm by attenuating generation of reactive oxygen species and apoptosis.
    Krishna SM; Li J; Wang Y; Moran CS; Trollope A; Huynh P; Jose R; Biros E; Ma J; Golledge J
    Sci Rep; 2021 Aug; 11(1):17451. PubMed ID: 34465809
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inflammasome activation by mitochondrial oxidative stress in macrophages leads to the development of angiotensin II-induced aortic aneurysm.
    Usui F; Shirasuna K; Kimura H; Tatsumi K; Kawashima A; Karasawa T; Yoshimura K; Aoki H; Tsutsui H; Noda T; Sagara J; Taniguchi S; Takahashi M
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):127-36. PubMed ID: 25378412
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MiR-126a-5p limits the formation of abdominal aortic aneurysm in mice and decreases ADAMTS-4 expression.
    Li L; Ma W; Pan S; Li Y; Wang H; Wang B; Khalil RA
    J Cell Mol Med; 2020 Jul; 24(14):7896-7906. PubMed ID: 32469162
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Resolvin D1 decreases abdominal aortic aneurysm formation by inhibiting NETosis in a mouse model.
    Spinosa M; Su G; Salmon MD; Lu G; Cullen JM; Fashandi AZ; Hawkins RB; Montgomery W; Meher AK; Conte MS; Sharma AK; Ailawadi G; Upchurch GR
    J Vasc Surg; 2018 Dec; 68(6S):93S-103S. PubMed ID: 30470363
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacologic inhibition of transient receptor channel vanilloid 4 attenuates abdominal aortic aneurysm formation.
    Shannon AH; Elder CT; Lu G; Su G; Mast A; Salmon MD; Montgomery WG; Spinosa MD; Upchurch GR; Sharma AK
    FASEB J; 2020 Jul; 34(7):9787-9801. PubMed ID: 32506673
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cyclodextrin Prevents Abdominal Aortic Aneurysm via Activation of Vascular Smooth Muscle Cell Transcription Factor EB.
    Lu H; Sun J; Liang W; Chang Z; Rom O; Zhao Y; Zhao G; Xiong W; Wang H; Zhu T; Guo Y; Chang L; Garcia-Barrio MT; Zhang J; Chen YE; Fan Y
    Circulation; 2020 Aug; 142(5):483-498. PubMed ID: 32354235
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Age-Associated Sirtuin 1 Reduction in Vascular Smooth Muscle Links Vascular Senescence and Inflammation to Abdominal Aortic Aneurysm.
    Chen HZ; Wang F; Gao P; Pei JF; Liu Y; Xu TT; Tang X; Fu WY; Lu J; Yan YF; Wang XM; Han L; Zhang ZQ; Zhang R; Zou MH; Liu DP
    Circ Res; 2016 Oct; 119(10):1076-1088. PubMed ID: 27650558
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tributyrin Intake Attenuates Angiotensin II-Induced Abdominal Aortic Aneurysm in
    Lin CP; Huang PH; Chen CY; Tzeng IS; Wu MY; Chen JS; Chen JW; Lin SJ
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175712
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 5-Lipoxygenase pathway in experimental abdominal aortic aneurysms.
    Bhamidipati CM; Whatling CA; Mehta GS; Meher AK; Hajzus VA; Su G; Salmon M; Upchurch GR; Owens GK; Ailawadi G
    Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2669-78. PubMed ID: 25324573
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Apelin protects against abdominal aortic aneurysm and the therapeutic role of neutral endopeptidase resistant apelin analogs.
    Wang W; Shen M; Fischer C; Basu R; Hazra S; Couvineau P; Paul M; Wang F; Toth S; Mix DS; Poglitsch M; Gerard NP; Bouvier M; Vederas JC; Penninger JM; Kassiri Z; Oudit GY
    Proc Natl Acad Sci U S A; 2019 Jun; 116(26):13006-13015. PubMed ID: 31189595
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Suppression of abdominal aortic aneurysm formation by AR-R17779, an agonist for the α7 nicotinic acetylcholine receptor.
    Watanabe A; Ichiki T; Kojima H; Takahara Y; Hurt-Camejo E; Michaëlsson E; Sankoda C; Ikeda J; Inoue E; Tokunou T; Kitamoto S; Sunagawa K
    Atherosclerosis; 2016 Jan; 244():113-20. PubMed ID: 26613536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.